Free Trial
ETR:MDG1

Medigene (MDG1) Stock Price, News & Analysis

Medigene logo
€0.13 0.00 (0.00%)
As of 05/15/2025

About Medigene Stock (ETR:MDG1)

Key Stats

Today's Range
€0.13
€0.13
50-Day Range
€0.13
€0.13
52-Week Range
€1.60
€5.51
Volume
N/A
Average Volume
306,207 shs
Market Capitalization
€1.02 million
P/E Ratio
N/A
Dividend Yield
1.31%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MDG1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medigene and its competitors with MarketBeat's FREE daily newsletter.

MDG1 Stock News Headlines

Medigene verlässt Prime Standard wegen Insolvenzverfahren
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

MDG1 Stock Analysis - Frequently Asked Questions

Medigene's stock was trading at €1.03 at the beginning of the year. Since then, MDG1 stock has decreased by 87.0% and is now trading at €0.13.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medigene investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX) and Ampio Pharmaceuticals (AMPE).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ETR:MDG1
CIK
N/A
Fax
N/A
Employees
76
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
(€0.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
7.12
Net Income
-€4.67 million
Net Margins
-249.83%
Pretax Margin
N/A
Return on Equity
-80.38%
Return on Assets
-27.15%

Debt

Debt-to-Equity Ratio
12.95
Current Ratio
2.39
Quick Ratio
5.85

Sales & Book Value

Annual Sales
€1.87 million
Price / Sales
0.54
Cash Flow
€0.10 per share
Price / Cash Flow
1.37
Book Value
€0.72 per share
Price / Book
0.18

Miscellaneous

Outstanding Shares
7,619,243
Free Float
N/A
Market Cap
€1.02 million
Optionable
Not Optionable
Beta
0.84
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ETR:MDG1) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners